A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1
Background Duchenne muscular dystrophy (DMD) is a progressive muscle disease caused by the loss of dystrophin, which results in inflammation, fibrosis, and the inhibition of myoblast differentiation in skeletal muscle. Catalpol, an iridoid glycoside, improves skeletal muscle function by enhancing my...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2020-10-01
|
| Edice: | Journal of Cachexia, Sarcopenia and Muscle |
| Témata: | |
| On-line přístup: | https://doi.org/10.1002/jcsm.12581 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|